| Article

A narrative review of minocycline—a 2nd-generation, semi-synthetic tetracycline used as a broad-spectrum antibiotic with anti-inflammatory properties—was performed by researchers evaluating its effectiveness in lessening neuropathic pain. Results were published in the Journal of Pain Research. A...

| Article

In an article in the PNAS journal, researchers report the power of 3 antibiotics against chronic pain, possibly reducing the need for opioids. The study abstract reports that “demeclocycline, chlortetracycline, and minocycline can be repurposed for treatment of neuropathic pain and potentially for...

| Article

Neuropathic pain—from an injury or disease of the peripheral and/or somatosensory nervous system—is usually severe and chronic, resistant to treatment, and therefore challenging for clinicians attempting to help patients. Researchers noted the high impact of neuropathic pain: "Many people with...

| Article

In a Journal of Nursing Scholarship article, published online ahead of print, type 2 diabetes patients experienced pain and fatigue reduction through relaxation and mindfulness techniques.

Click here for more information about mindfulness on PAINWeek.org.

 

Purpose: To examine the effects...

| Article

Newswise — Researchers from Joslin Diabetes Center, using a genome-wide association study, have identified a genetic factor linked to the development of diabetic peripheral neuropathy. This finding suggests a new target for preventive therapies. The research has been published online and will appear...

| Article

A review conducted by researchers from University of Sydney concludes that people with type 2 diabetes are at 35% greater risk for low back pain and 24% higher risk for experiencing neck pain. The findings were derived from a meta-analysis of studies examining possible connections between the...

Subscribe to diabetic peripheral neuropathy

Sign-Up